DARRYLYNN SMITH: Open Payments
NPI 1932643400 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 28 payments from 6 companies in 2025. Trend: 2023 $168 · 2024 $37 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $299 |
| Teva Pharmaceuticals USA, Inc. | 4 | $271 |
| Janssen Pharmaceuticals, Inc | 5 | $191 |
| Otsuka America Pharmaceutical, Inc. | 2 | $97 |
| Alkermes, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: COBENFY, AUSTEDO XR, INVEGA, ABILIFY MAINTENA, ARISTADA, UZEDY, ABILIFY ASIMTUFII, FANAPT.
Industry payments across LA — which companies pay providers there.
